TNF and metabolic dysfunction-associated steatotic liver disease: In addition, it downregulated inflammatory genes in the p38 mitogen‐activated protein kinase (MAPK)/TNF‐α/NF‐ƙB pathway, supporting the use of C. vulgaris supplements as potential adjuvant therapy for NAFLD.[243]